Sarcoid-like lesions obfuscating the diagnosis of disseminated Mycobacterium genavense infection in a patient with IL-12Rβ1-associated immunodeficiency.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
04 Oct 2022
Historique:
received: 27 04 2022
accepted: 24 07 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 6 10 2022
Statut: epublish

Résumé

Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating epithelioid-cell granulomas upon histology. However, similar histological findings may also be seen with certain infections. Thus, differentiation from infection is pivotal to ensure appropriate treatment. Here, we present a case of a disseminated infection with Mycobacterium genavense owing to an interleukin 12 receptor subunit beta 1 (IL-12Rβ1) associated immunodeficiency in a previously healthy female who was initially misdiagnosed with sarcoidosis. M. genavense is a nontuberculous mycobacterium which can cause lymphadenopathy, gastrointestinal and bone marrow infiltration in immunocompromised patients. With this case report we aim to highlight that an infection with M. genavense on the ground of a genetic defect of mycobacterial immune control may represent a rare differential diagnosis of sarcoidosis. A 31-year-old female was referred to our hospital with progressive lymphadenopathy, hepatosplenomegaly, pancytopenia and systemic inflammation. She had previously been evaluated for generalized lymphadenopathy in another hospital. At that time, lymph node biopsies had revealed sarcoid-like lesions and a systemic corticosteroid treatment was initiated based on a putative diagnosis of sarcoidosis. When her condition worsened, she was transferred to our university clinic, where the diagnosis of disseminated M. genavense infection owing to an inborn interferonopathy was made. Her family history revealed that her brother had also suffered from IL-12Rβ1 deficiency and had died from a systemic infection with M. genavense at the age of 21. The patient received antimycobacterial treatment combined with subcutaneous type I interferon, which eventually led to a gradual improvement over the next months. Differentiating between sarcoidosis and sarcoid-like lesions secondary to infections may be challenging, especially when pathogens are difficult to detect or not expected in an apparently immunocompetent patient. Patients with IL-12Rβ1-associated immunodeficiency may be asymptomatic until adulthood, and disseminated M. genavense infection on the grounds of an IL-12Rβ1-associated immunodeficiency may represent a rare differential diagnosis of sarcoidosis.

Sections du résumé

BACKGROUND BACKGROUND
Sarcoidosis is a systemic inflammatory disease that is characterized by non-caseating epithelioid-cell granulomas upon histology. However, similar histological findings may also be seen with certain infections. Thus, differentiation from infection is pivotal to ensure appropriate treatment. Here, we present a case of a disseminated infection with Mycobacterium genavense owing to an interleukin 12 receptor subunit beta 1 (IL-12Rβ1) associated immunodeficiency in a previously healthy female who was initially misdiagnosed with sarcoidosis. M. genavense is a nontuberculous mycobacterium which can cause lymphadenopathy, gastrointestinal and bone marrow infiltration in immunocompromised patients. With this case report we aim to highlight that an infection with M. genavense on the ground of a genetic defect of mycobacterial immune control may represent a rare differential diagnosis of sarcoidosis.
CASE PRESENTATION METHODS
A 31-year-old female was referred to our hospital with progressive lymphadenopathy, hepatosplenomegaly, pancytopenia and systemic inflammation. She had previously been evaluated for generalized lymphadenopathy in another hospital. At that time, lymph node biopsies had revealed sarcoid-like lesions and a systemic corticosteroid treatment was initiated based on a putative diagnosis of sarcoidosis. When her condition worsened, she was transferred to our university clinic, where the diagnosis of disseminated M. genavense infection owing to an inborn interferonopathy was made. Her family history revealed that her brother had also suffered from IL-12Rβ1 deficiency and had died from a systemic infection with M. genavense at the age of 21. The patient received antimycobacterial treatment combined with subcutaneous type I interferon, which eventually led to a gradual improvement over the next months.
CONCLUSIONS CONCLUSIONS
Differentiating between sarcoidosis and sarcoid-like lesions secondary to infections may be challenging, especially when pathogens are difficult to detect or not expected in an apparently immunocompetent patient. Patients with IL-12Rβ1-associated immunodeficiency may be asymptomatic until adulthood, and disseminated M. genavense infection on the grounds of an IL-12Rβ1-associated immunodeficiency may represent a rare differential diagnosis of sarcoidosis.

Identifiants

pubmed: 36192705
doi: 10.1186/s12879-022-07644-4
pii: 10.1186/s12879-022-07644-4
pmc: PMC9531490
doi:

Substances chimiques

Interferon Type I 0
Receptors, Interleukin-12 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

770

Informations de copyright

© 2022. The Author(s).

Références

Hum Mol Genet. 2005 Dec 15;14(24):3847-55
pubmed: 16293671
Am J Respir Cell Mol Biol. 2011 Nov;45(5):899-905
pubmed: 21659662
Semin Immunol. 2014 Dec;26(6):454-70
pubmed: 25453225
Patholog Res Int. 2014;2014:371370
pubmed: 24693456
Crit Rev Clin Lab Sci. 2018 May;55(3):184-204
pubmed: 29502462
Immunol Rev. 2015 Mar;264(1):182-203
pubmed: 25703560
Balkan Med J. 2013 Mar;30(1):13-5
pubmed: 25207061
J Clin Microbiol. 1996 Jul;34(7):1840-2
pubmed: 8784607
Int J Syst Bacteriol. 1993 Oct;43(4):841-3
pubmed: 8240965
Clin Microbiol Infect. 2018 Dec;24(12):1355-1356
pubmed: 30036670
J Clin Microbiol. 1995 Sep;33(9):2514-5
pubmed: 7494064
Medicine (Baltimore). 2010 Nov;89(6):381-402
pubmed: 21057261
Infect Dis (Lond). 2018 May;50(5):329-339
pubmed: 29157060
N Engl J Med. 2021 Sep 9;385(11):1018-1032
pubmed: 34496176
Scand J Infect Dis. 1999;31(1):63-8
pubmed: 10381220
Clin Microbiol Infect. 2022 Mar 11;:
pubmed: 35283318
Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26-e51
pubmed: 32293205

Auteurs

Sara Denicolò (S)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Department of Internal Medicine IV (Nephrology and Hypertensiology), Medical University Innsbruck, 6020, Innsbruck, Austria.

Sophie Laydevant (S)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

Julia Fink (J)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

Christoph Geiger (C)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

Alex Pizzini (A)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

Mario Sarcletti (M)

Department of Dermatology, Venereology and Allergology, Medical University Innsbruck, 6020, Innsbruck, Austria.

Johannes Zschocke (J)

Institute of Human Genetics, Medical University Innsbruck, 6020, Innsbruck, Austria.

Rosa Bellmann-Weiler (R)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

Günter Weiss (G)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria. guenter.weiss@i-med.ac.at.

Ivan Tancevski (I)

Department of Internal Medicine II (Infectious Diseases, Pneumology and Rheumatology), Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria. ivan.tancevski@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH